Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler (original ) (raw )Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD
Aino Takala
International Journal of Chronic Obstructive Pulmonary Disease
View PDFchevron_right
Influence of Peak Inspiratory Flow Rates and Pressure Drops on Inhalation Performance of Dry Powder Inhalers
Tomoyuki Okuda
Chemical and Pharmaceutical Bulletin, 2012
View PDFchevron_right
Peak Inspiratory Flow Measured at Different Inhaler Resistances in Patients with Asthma
Eddie McKnight
The Journal of Allergy and Clinical Immunology: In Practice, 2021
View PDFchevron_right
Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes
Will Carroll
Advances in Therapy
View PDFchevron_right
Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD
Sara Barile
BMC Pulmonary Medicine, 2021
View PDFchevron_right
In Vitro Dosing Performance of the ELLIPTA(®) Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)
Melanie Hamilton
Journal of aerosol medicine and pulmonary drug delivery, 2015
View PDFchevron_right
The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates
Rajiv Dhand
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2019
View PDFchevron_right
[Patient preference in the choice of dry powder inhalers]
Joaquín Sanchis
2004
View PDFchevron_right
Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler
Diego Copelli
Pharmaceutical Research, 2015
View PDFchevron_right
Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD
Alexander Duarte
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
View PDFchevron_right
Impact of human behavior on inspiratory flow profiles in patients with pulmonary arterial hypertension using AOS™ dry powder inhaler device
Jeffry Weers
Pulmonary Circulation
View PDFchevron_right
Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
Ioanna Tsiligianni
npj Primary Care Respiratory Medicine
View PDFchevron_right
Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices
Hiroyoshi Koide
PLOS ONE, 2018
View PDFchevron_right
Assessment of patterns of use of Dry powder inhaler (DPI), pressurized Metered dose inhaler (MDI), Nebulizer, DPI with MDI, DPI with Nebulizer, MDI with Nebulizer and the combination of DPI, MDI and Nebulizer, in patients with Asthma, Chronic obstructive
Fahad Abdullah
International Journal of Research in Pharmacology & Pharmacotherapeutics, 2018
View PDFchevron_right
Use of dry powder inhalers in acute exacerbations of asthma and COPD
Olof Selroos
Therapeutic Advances in Respiratory Disease, 2009
View PDFchevron_right
Clinical recommendations for dry powder inhaler use in the management of COPD in primary care
Ioanna Tsiligianni
npj Primary Care Respiratory Medicine
View PDFchevron_right
Rational design of a dry powder inhaler: device design and optimisation
Hartwig Steckel
Journal of Pharmacy and Pharmacology, 2012
View PDFchevron_right
Inspiratory Flows and Volumes in Subjects with Cystic Fibrosis Using a New Dry Powder Inhaler Device
Sandra D Anderson
The Open Respiratory Medicine Journal, 2014
View PDFchevron_right
The Impact of Flow rate on Inhaler Dose Delivery from a Dry Powder Inhaler using a Two Stage Impinger
Huner Omer
ZANCO JOURNAL OF PURE AND APPLIED SCIENCES, 2018
View PDFchevron_right
Clinically Relevant In Vitro Performance Tests for Powder Inhalers
Xiangyin Wei
2016
View PDFchevron_right
Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler
David Geller
Respiratory care, 2005
View PDFchevron_right
Sensitivity And Specificity Of An Acoustic Method For Calculating Peak Inspiratory Flow Rate And Inspiratory Volume Through A Diskus Dry Powder Inhaler
E. Machale
View PDFchevron_right
Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection
Szilvia Kugler
Respiratory Medicine, 2019
View PDFchevron_right
Suboptimal Inspiratory Flow Rates With Passive Dry Powder Inhalers: Big Issue or Overstated Problem?
Jeffry Weers
Frontiers in Drug Delivery
View PDFchevron_right
Clickhaler (a Novel Dry Powder Inhaler) Provides Similar Bronchodilation to Pressurized Metered-Dose Inhaler, Even at Low Flow Rates*
Carole Chambers
CHEST Journal, 1999
View PDFchevron_right
In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy
herbert wachtel
International Journal of Chronic Obstructive Pulmonary Disease, 2017
View PDFchevron_right
Goals of Inhalation Therapy Dry Powder Inhalers DPI Use During Mechanical Ventilation
Rajiv Dhand
2015
View PDFchevron_right
Experimental Lung Research Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers
Ahmed A Elberry
View PDFchevron_right
The ELLIPTA(®) Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers
Melanie Hamilton
Journal of aerosol medicine and pulmonary drug delivery, 2015
View PDFchevron_right
Effects of Device and Formulation on In Vitro Performance of Dry Powder Inhalers
Bill Doub
The AAPS Journal, 2012
View PDFchevron_right